6 Apr

Cannabis legislation opens the door for pharmaceutical brands in Latin America

With new legislation regulating the use of cannabis-based medicines in Argentina and Brazil, the emerging market is an open playing field for pharmaceutical brands looking to make their mark in Latin America.

Daniela Lin


H&A, Brazil

[email protected]

Guillermo Alcaraz

Head of the trademark department

H&A, Argentina

[email protected]